Palogic Value Management’s LivePerson LPSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,833
Closed -$110K 167
2024
Q4
$110K Sell
4,833
-21,834
-82% -$334K 0.04% 170
2024
Q3
$512K Sell
26,667
-7,566
-22% -$128K 0.17% 118
2024
Q2
$298 Buy
34,233
+18,743
+121% +$180K ﹤0.01% 162
2024
Q1
$232K Sell
15,490
-41,605
-73% -$1.43M 0.1% 142
2023
Q4
$3.25M Buy
57,095
+31,088
+120% +$1.43M 1.44% 18
2023
Q3
$1.52M Sell
26,007
-13,313
-34% -$876K 0.72% 52
2023
Q2
$2.67M Buy
39,320
+6,666
+20% +$432K 1.25% 20
2023
Q1
$2.16M Buy
32,654
+11,321
+53% +$1.81M 1.06% 25
2022
Q4
$3.24M Buy
+21,333
New +$3.42M 1.69% 15

Other funds holding LPSN

Palogic Value Management's LPSN Position: Q1 2025 in Review

Palogic Value Management sold out of LivePerson (LPSN) in Q1 2025, closing a stake of 4,833 shares — an estimated $110K sold.

Palogic Value Management first reported a position in LPSN in Q4 2022 and held it in 9 quarters. The position peaked at $3.25M in Q4 2023. 70 funds tracked by Wall St. Rank hold LPSN as of Q1 2025.

  • Palogic Value Management reported no remaining LivePerson position as of Q1 2025 after selling out during the quarter.
  • Palogic Value Management sold 4,833 LivePerson shares in Q1 2025, an estimated $110K.
  • Palogic Value Management first reported a position in LivePerson in Q4 2022 and held it in 9 quarters.
  • Palogic Value Management's LivePerson position peaked at $3.25M in Q4 2023.
  • 70 funds tracked by Wall St. Rank held LivePerson as of Q1 2025.

Based on Palogic Value Management's 13F filing for Q1 2025, filed 15 May 2025.